Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis (2015)
- Authors:
- USP affiliated authors: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; ZUARDI, ANTONIO WALDO - FMRP
- Unidade: FMRP
- DOI: 10.2174/1871527314666150909113930
- Subjects: CANABINOIDES; TRANSTORNOS PSICÓTICOS; ESQUIZOFRENIA; FÁRMACOS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: CNS & Neurological Disorders - Drug Targets
- ISSN: 1996-3181
- Volume/Número/Paginação/Ano: v. 14, n. 8, p. 970-978, 2015
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis. CNS & Neurological Disorders - Drug Targets, v. 14, n. 8, p. 970-978, 2015Tradução . . Disponível em: https://doi.org/10.2174/1871527314666150909113930. Acesso em: 21 maio 2024. -
APA
Crippa, J. A. de S., Hallak, J. E. C., Abilio, V. C., Lacerda, A. L. T., & Zuardi, A. W. (2015). Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis. CNS & Neurological Disorders - Drug Targets, 14( 8), 970-978. doi:10.2174/1871527314666150909113930 -
NLM
Crippa JA de S, Hallak JEC, Abilio VC, Lacerda ALT, Zuardi AW. Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis [Internet]. CNS & Neurological Disorders - Drug Targets. 2015 ; 14( 8): 970-978.[citado 2024 maio 21 ] Available from: https://doi.org/10.2174/1871527314666150909113930 -
Vancouver
Crippa JA de S, Hallak JEC, Abilio VC, Lacerda ALT, Zuardi AW. Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis [Internet]. CNS & Neurological Disorders - Drug Targets. 2015 ; 14( 8): 970-978.[citado 2024 maio 21 ] Available from: https://doi.org/10.2174/1871527314666150909113930 - Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
- Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol: an anxiolytic or an antipsychotic new drug?
- Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update
- Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
Informações sobre o DOI: 10.2174/1871527314666150909113930 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
